We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Inpeco

Inpeco is a global leader in automation systems for clinical laboratories and designs cutting-edge solutions for both... read more Featured Products: More products

Download Mobile App




Next-Generation Total Lab Automation Solution Boosts Performance and Productivity

By LabMedica International staff writers
Posted on 20 May 2025

A new total lab automation system premiering in Europe is expected to set new benchmarks in flexibility, user experience, and performance. More...

FlexLab X, the next-generation automation system from Inpeco (Novazzano, Switzerland), has made its European debut after being unveiled at the 2025 EuroMedLab held in Brussels, Belgium. Designed to meet the needs of laboratories, FlexLab X aims to streamline workflows to the maximum – for enhanced clinical, operational, and financial outcomes. FlexLab X is a uniquely open automation system allowing labs to freely combine the analyzers of their choice from various vendors – for premium-quality results. With 12 specialties and 30 analyzers connected to date, labs can freely combine the best-of-breed analyzers from various vendors, for optimal patient outcomes. Currently, connections are available for clinical chemistry, immunoassay, hematology, ESR and HbA1c, urinalysis, molecular biology, allergy, plasma proteins, coagulation, blood screening, and FOB. The number of new analyzer connections supporting a wide range of clinical specialties is steadily growing to keep labs in touch with the future. Additionally, FlexLab X is flexible and scalable by design, thanks to standardized components that facilitate space-saving layouts tailored to specific needs and simplify future upgrades.

Designed to increase laboratory efficiency, enhance quality, and reduce cost, FlexLab X modules deliver maximum performance, while the DMX software (Data Management FlexLab X) guarantees intelligent tube routing with full sample traceability and easy performance monitoring using KPI dashboards. Harnessing the power of continuous automation monitoring, using KPI dashboards and customizable reports, DMX software helps labs optimize their clinical, operational, and financial performance. Combined, they ensure rapid and consistent turnaround times at all volume levels, as well as a best-in-class user experience. FlexLab X offers a wide range of high performing pre- and post-analytical modules to build the automation dream – be it on one single floor, or connecting several floors. They are easy to use, quiet and reliable, and feature compact dimensions to make the best use of precious lab space.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

High-grade serous ovarian cancer is often diagnosed at an advanced stage, limiting opportunities for early intervention. The disease frequently originates in the fallopian tube as serous tubal intraepithelial... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.